COSA 2015* , ,
Presentations this author is a contributor to:
Nivolumab (Nivo) monotherapy or in combination with ipilimumab (Ipi) for treatment of recurrent small cell lung cancer (SCLC) (#187)
3:00 PM
Emiliano Calvo
Posters1